Physician profile
Alan Tran
NPI 1154826840
$1,495.83
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.21 · 2020: $35.17 · 2021: $17.66 · 2022: $169 · 2023: $936 · 2024: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,147 · Education: $83.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,147.16 |
| Education | $83.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Painteq LLC | $478.00 | 2023-2024 | Painteq |
| Medtronic, INC. | $351.94 | 2022-2023 | Intellis Adaptivestim |
| Spr Therapeutics, INC | $218.21 | 2023 | Sprint Pns System |
| Becton, Dickinson and Company | $180.46 | 2024 | Hemosphere |
| Merck Sharp & Dohme LLC | $79.05 | 2019-2022 | |
| Saluda Medical Americas, INC. | $58.29 | 2023 | Evoke Scs |
| Mindray Ds USA, INC. | $49.92 | 2022 | |
| Glaxosmithkline, LLC. | $35.17 | 2020 | |
| Curonix LLC | $24.75 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Teva Pharmaceuticals USA, INC. | $20.04 | 2023 | Austedo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.